RPRX

Royalty Pharma plc [RPRX] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

RPRX Stock Summary

Top 10 Correlated ETFs

RPRX

Top 10 Correlated Stocks

RPRX

In the News

RPRX Financial details

Company Rating
-
Market Cap
12.61B
Income
1.13B
Revenue
2.35B
Book val./share
-
Cash/share
-
Dividend
0.8
Dividend %
2.82%
Employees
75
Optionable
No
Shortable
Yes
Earnings
09 May 2024
P/E
418.94
Forward P/E
-
PEG
1.68
P/S
7.33
P/B
2.07
P/C
-
P/FCF
6.12
Quick Ratio
13.46
Current Ratio
13.51
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
2.54
EPS next Y
-
EPS next Q
-
EPS this Y
2497.14%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-16.93%
Revenue last 5Y
5.35%
Revenue Q/Q
11.13%
EPS Q/Q
593.75%
-
-
-
-
SMA20
-3.7%
SMA50
1.33%
SMA100
23.08%
Inst Own
-
Inst Trans
-
ROA
-
ROE
1%
ROC
0.06%
Gross Margin
100%
Oper. Margin
42%
Profit Margin
1%
Payout
1165%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
25.92-36.67
52W High
-10.58%
52W Low
+28.76%
RSI
50.74
Rel Volume
0.76
Avg Volume
2.71M
Volume
2.07M
Perf Week
-0.25%
Perf Month
-2.48%
Perf Quarter
18%
Perf Half Y
16%
-
-
-
-
Beta
0.446
-
-
Volatility
0.42%, 0.89%
Prev Close
-1.26%
Price
32.19
Change
0.31%

RPRX Financial Performance

RPRX Dividend History

RPRX Frequently Asked Questions

What is Royalty Pharma plc stock symbol ?

Royalty Pharma plc is a US stock , located in New york of Ny and trading under the symbol RPRX

What is Royalty Pharma plc stock quote today ?

Royalty Pharma plc stock price is $32.19 today.

Is Royalty Pharma plc stock public?

Yes, Royalty Pharma plc is a publicly traded company.

Something similar

Top by Market Cap
JPM
DHR-PB
0YXG.L
ABEC.DE
AVGO
Top Correlated ETFs
USFR
TBUX
ARKG
NLR
XFR.TO
Top Correlated Stocks
600233.SS
9009.T
9428.T
COCO
HMC
Similar Market Cap
2315.T
PKG
0QYK.L
000550.SZ
600821.SS

Company Profile

Healthcare Biotechnology
  • Volume Average 2.71M
  • Market Capitalization 12.61B
  • Employee 75
  • CEO Mr. Pablo Gerardo Legorreta
  • Headquarters New York,NY,US
  • IPO Date 2020-06-16
  • Website https://www.royaltypharma.com

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 marketed therapies and 10 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neurology, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.